Old Web
English
Sign In
Acemap
>
authorDetail
>
Niranjan Kanesa-thasan
Niranjan Kanesa-thasan
Novartis
Medicine
Virus
Virology
Immunology
Vaccination
5
Papers
112
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Safety and Immunogenicity of Cell Culture-Derived A/H3N2 Variant Influenza Vaccines: A Phase I Randomized, Observer-Blind, Dose-Ranging Study
2015
The Journal of Infectious Diseases
Casey Johnson
Matthew Hohenboken
Terry Poling
Peter Jaehnig
Niranjan Kanesa-thasan
Show All
Source
Cite
Save
Citations (4)
A Cell Culture–Derived MF59-Adjuvanted Pandemic A/H7N9 Vaccine Is Immunogenic in Adults
2014
Science Translational Medicine
Stephan A. Bart
Matthew Hohenboken
Giovanni Della Cioppa
Vas Narasimhan
Philip R. Dormitzer
Niranjan Kanesa-thasan
Show All
Source
Cite
Save
Citations (78)
Vaccinating against Japanese encephalitis virus: what have we learned from recent clinical trials?
2012
Expert Review of Vaccines
Katrin Dubischar-Kastner
Niranjan Kanesa-thasan
Show All
Source
Cite
Save
Citations (7)
Manufacturers' postmarketing safety surveillance of influenza vaccine exposure in pregnancy
2012
American Journal of Obstetrics and Gynecology
Alena Khromava
Christopher Cohen
Marie Mazur
Niranjan Kanesa-thasan
Antonio Crucitti
Harry Seifert
Show All
Source
Cite
Save
Citations (8)
Ensuring the Optimal Safety of Licensed Vaccines: A Perspective of the Vaccine Research, Development, and Manufacturing Companies
2011
Pediatrics
Niranjan Kanesa-thasan
Alan Shaw
Jeffrey J. Stoddard
Thomas M. Vernon
Show All
Source
Cite
Save
Citations (15)
1